Amiodarone as a First-Choice Drug for Restoring Sinus Rhythm in Patients With Atrial Fibrillation
Authors:
- Panos E. VardasPVPanos E. Vardas
- George E. KochiadakisGKGeorge E. Kochiadakis
- Nikos E. IgoumenidisNINikos E. Igoumenidis
- Aristidis M. TsatsakisAristidis M. Tsatsakis
- Emmanuel N. SimantirakisESEmmanuel N. Simantirakis
- Gregory I. ChlouverakisGCGregory I. Chlouverakis
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adverse Effects of AmiodaronePacing and Clinical Electrophysiology, 1998
- Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart FailureCirculation, 1996
- Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled studyJACC, 1996
- Newer developments in the management of atrial fibrillationAmerican Heart Journal, 1995
- Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillationThe American Journal of Cardiology, 1995
- Current management of atrial fibrillationCurrent Opinion in Cardiology, 1994
- Low-dose amiodarone for atrial fibrillationThe American Journal of Cardiology, 1993
- Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertensionThe American Journal of Cardiology, 1992
- Management of Atrial FibrillationNew England Journal of Medicine, 1992
- Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1990